Suppr超能文献

针对胸膜感染中不伴有支气管胸膜瘘的局限性积液,采用连续两个疗程的组织型纤溶酶原激活剂/脱氧核糖核酸酶治疗。

Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection.

作者信息

Popowicz Natalia, Piccolo Francesco, Shrestha Ranjan, Lee Y C Gary

机构信息

Pharmacy Department, Sir Charles Gairdner Hospital Perth, Western Australia, Australia ; Centre for Asthma, Allergy & Respiratory Research, School of Medicine & Pharmacology, University of Western Australia Perth, Western Australia, Australia.

Department of Medicine, Swan District Hospital Perth, Western Australia, Australia.

出版信息

Respirol Case Rep. 2014 Jun;2(2):87-9. doi: 10.1002/rcr2.58. Epub 2014 May 4.

Abstract

Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) therapy is being increasingly employed as an alternative to surgical intervention for the treatment of complicated parapneumonic effusions and empyema. Published cases are limited to one randomized control trial and few case reports. No data exist on employing sequential or repeated courses of intrapleural tPA/DNase to aid evacuation of separate collections in patients' with a multiloculated pleural infection. This is the first report of successful use of sequential delivery of separate courses of intrapleural tPA/DNase to two noncommunicating infected pleural fluid collections within the same hemithorax of a patient. Our case confirms that prior treatment with tPA/DNase therapy does not preclude subsequent effective and safe use of this intrapleural treatment.

摘要

胸膜内组织纤溶酶原激活剂(tPA)和脱氧核糖核酸酶(DNase)疗法正越来越多地被用作手术干预的替代方法,用于治疗复杂性肺炎旁胸腔积液和脓胸。已发表的病例仅限于一项随机对照试验和少数病例报告。对于在多房性胸膜感染患者中采用序贯或重复疗程的胸膜内tPA/DNase以帮助排出不同的积液,尚无相关数据。本文首次报告了在同一患者半侧胸腔内,对两个不连通的感染性胸腔积液采用序贯给予不同疗程胸膜内tPA/DNase并取得成功的案例。我们的病例证实,先前使用tPA/DNase疗法进行治疗并不妨碍随后安全有效地使用这种胸膜内治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f930/4184516/ca3f0f859909/rcr20002-0087-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验